Low-dose retinoids in the prevention of cutaneous squamous cell carcinomas in organ transplant recipients: a 16-year retrospective study
CA Harwood, M Leedham-Green, IM Leigh… - Archives of …, 2005 - jamanetwork.com
Objective To evaluate the long-term efficacy of systemic retinoids in reducing the incidence
of cutaneous squamous cell carcinomas (SCCs) in organ transplant recipients (OTRs), who
are at greatly increased risk of SCCs. Design A retrospective before-after study of OTRs who
had received low-dose systemic retinoids during 1 to 16 years for prevention of SCCs.
Setting A specialist dermatology clinic for organ transplant recipients at St Bartholomew's
and the Royal London Hospital, University of London, London, England. Patients Thirty-two …
of cutaneous squamous cell carcinomas (SCCs) in organ transplant recipients (OTRs), who
are at greatly increased risk of SCCs. Design A retrospective before-after study of OTRs who
had received low-dose systemic retinoids during 1 to 16 years for prevention of SCCs.
Setting A specialist dermatology clinic for organ transplant recipients at St Bartholomew's
and the Royal London Hospital, University of London, London, England. Patients Thirty-two …